The Colombian Medical Cannabis Paradox: A Scoping Review of Structural Barriers and Health Inequity
Abstract Background: Law 1787 of 2016 established Colombia’s medical cannabis framework, intended as a public policy to improve health equity…
health equity
Youth vaping prevention with urban Indigenous communities of the southwest U.S.: a protocol for a randomized controlled trial
Abstract Background: Indigenous adolescents have the highest rates of nicotine vaping and tend to initiate at an earlier age compared…
State Medical Cannabis Policy Implementation and Racial Disparities in Opioid Prescribing Among Medicare Beneficiaries: A Policy Impact Analysis
Abstract Introduction: U.S. cannabis policies have a history of racial disparities, highlighting the need for research surrounding racial inequities, particularly…
Technology-Based Interventions for Substance Use Treatment Among People Who Identify as African American or Black, Hispanic or Latino, and American Indian or Alaska Native: Scoping Review
Abstract Background: In the United States, racial and ethnic disparities in substance use treatment outcomes are persistent, especially among underrepresented…
Universal substance use care for adolescents with chronic medical conditions: a protocol to examine equitable implementation determinants and strategies for SBIRT at a pediatric hospital
Abstract Background: Adolescents with chronic medical conditions (CMC) use alcohol and marijuana at levels equal to or even greater than…
Promoting diversity in clinical trials: insights from planning the ALUMNI AD study in historically underrepresented US populations with early symptomatic Alzheimer’s disease
Abstract Clinical trial participation across disease areas, including Alzheimer’s disease (AD), has been biased towards White participants of European ancestry.…
Assessing the risk of COVID-19 reinfection and severe outcomes among individuals with substance use disorders: a retrospective study using real-world electronic health records
Abstract Objective: Despite advancement in vaccines and treatments for COVID-19 over the past 2 years, many concerns remain about reinfection…